Seegene Overview
- Year Founded
-
2000
- Status
-
Public
- Employees
-
847
- Stock Symbol
-
096530
- Investments
-
9
- Share Price
-
$18.47
- (As of Friday Closing)
Seegene General Information
Description
SEEGENE Inc is engaged in the healthcare sector. The Korean firm specializes in developing upgraded technology for accurate diagnosis of various diseases. Its products include pathogen inspection solutions such as respiratory, gastrointestinal, tuberculosis and meningitis pathogens.
Contact Information
Website
kr.seegene.comCorporate Office
- Taewon Building
- 91 Ogeum-ro Songpa-gu
- Seoul, 05548
- South Korea
Corporate Office
- Taewon Building
- 91 Ogeum-ro Songpa-gu
- Seoul, 05548
- South Korea
Seegene Stock Performance
As of 13-Nov-2026, Seegene’s stock price is $18.47. Its current market cap is $842M with 45.6M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $18.47 | $18.78 | $14.33 - $30.19 | $842M | 45.6M | 330K | $1.38 |
Seegene Financials Summary
As of 30-Jun-2026, Seegene has a trailing 12-month revenue of $351M.
|
In Thousands, USD |
TTM 30-Jun-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 567,583 | 467,379 | 452,357 | 524,142 |
| Revenue | 350,919 | 333,230 | 303,606 | 280,986 |
| EBITDA | 113,871 | 82,353 | 35,851 | 40,170 |
| Net Income | 63,217 | 33,921 | (6,420) | 512 |
| Total Assets | 820,530 | 858,187 | 826,124 | 971,112 |
| Total Debt | 84,453 | 90,230 | 97,486 | 110,007 |
Seegene Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Seegene Comparisons
Industry
Financing
Details
Seegene Competitors (1)
One of Seegene’s competitors is Wizbiosolutions, a Venture Capital-Backed company based in Seongnam, South Korea.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Wizbiosolutions | Venture Capital-Backed | Seongnam, South Korea |
Seegene Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Seegene Patents
Seegene Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026212328-A1 | Method for managing test result for sample and test result-management cloud server | Pending | 31-Mar-2025 | ||
| WO-2026147094-A1 | Device for continuous molecular testing | Pending | 31-Dec-2024 | ||
| WO-2026142346-A1 | Nucleic acid detection apparatus | Pending | 24-Dec-2024 | ||
| WO-2026135318-A1 | Method for providing clinical decision support information for disease identification and therapy determination based on product-tailored database, and device for performing the same | Pending | 19-Dec-2024 | ||
| WO-2026134924-A1 | Method for providing oligonucleotide of specific length including predictive thermodynamic characteristic information | Pending | 19-Dec-2024 |
Seegene Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Seegene Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Seegene Investments & Acquisitions (9)
Seegene’s most recent deal was a Merger/Acquisition with Dandy Mecca. The deal was made on 30-Sep-2025.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Dandy Mecca | 30-Sep-2025 | Merger/Acquisition | Machinery (B2B) | ||
| Diagnostic Products (Seegene / Werfen) | 27-May-2025 | Joint Venture | Diagnostic Equipment | ||
| Pentaworks | 10-Jun-2024 | Merger/Acquisition | IT Consulting and Outsourcing | ||
| Brex (IT Consulting and Outsourcing) | 15-Jan-2024 | Merger/Acquisition | IT Consulting and Outsourcing | ||
| Joint Venture (Hylab / Seegene) | 22-Mar-2023 | Joint Venture | Diagnostic Equipment |
Seegene ESG
Risk Overview
Risk Rating
Updated November, 04, 2026
26.05 | Med Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,592
Rank
Percentile
Healthcare
Industry
of 590
Rank
Percentile
Medical Devices
Subindustry
of 209
Rank
Percentile
Seegene Affiliates
Subsidiaries (2)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Brex (IT Consulting and Outsourcing) | Seoul, South Korea | 2019 | |
| Arrow Diagnostics | Genoa, Italy | 2003 |
Seegene FAQs
-
When was Seegene founded?
Seegene was founded in 2000.
-
Where is Seegene headquartered?
Seegene is headquartered in Seoul, South Korea.
-
What is the size of Seegene?
Seegene has 847 total employees.
-
What industry is Seegene in?
Seegene’s primary industry is Laboratory Services (Healthcare).
-
Is Seegene a private or public company?
Seegene is a Public company.
-
What is Seegene’s stock symbol?
The ticker symbol for Seegene is 096530.
-
What is the current stock price of Seegene?
As of 13-Nov-2026 the stock price of Seegene is $18.47.
-
What is the current market cap of Seegene?
The current market capitalization of Seegene is $842M.
-
What is Seegene’s current revenue?
The trailing twelve month revenue for Seegene is $351M.
-
Who are Seegene’s competitors?
Wizbiosolutions is a competitor of Seegene.
-
What is Seegene’s annual earnings per share (EPS)?
Seegene’s EPS for 12 months was $1.38.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
